Anavex Life Sciences (AVXL) EPS (Weighted Average and Diluted) Growth (1y) (2011 - 2025)
Anavex Life Sciences (AVXL) EPS (Weighted Average and Diluted) Growth (1y) (2011 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
251.11% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-13.31% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
102.51% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-79.34% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
-103.05% |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
61.45% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Anavex Life Sciences |
221.68 Mn |
89.93 Mn |
- |
57.14% |
| Date | Value |
|---|
| Dec 31, 2025 |
57.14% |
| Sep 30, 2025 |
21.43% |
| Jun 30, 2025 |
-14.29% |
| Mar 31, 2025 |
0.00% |
| Dec 31, 2024 |
-27.27% |
| Sep 30, 2024 |
-7.69% |
| Jun 30, 2024 |
0.00% |
| Mar 31, 2024 |
23.53% |
| Dec 31, 2023 |
33.88% |
| Sep 30, 2023 |
30.04% |
| Sep 30, 2022 |
-10.68% |
| Mar 31, 2017 |
33.33% |
| Dec 31, 2016 |
33.33% |
| Sep 30, 2016 |
14.29% |
| Jun 30, 2016 |
72.73% |
| Mar 31, 2016 |
50.00% |
| Dec 31, 2015 |
-100.00% |
| Sep 30, 2015 |
78.57% |
| Jun 30, 2015 |
-633.33% |
| Mar 31, 2015 |
-300.00% |
